Summary:
- This article discusses the ongoing legal battle surrounding the FDA's approval of mifepristone, a medication used for early-stage abortions.
- It examines the efforts by anti-abortion groups, led by Robert F. Kennedy Jr., to have mifepristone removed from the market, despite its established safety and efficacy.
- The article explores the potential impact of a court ruling against mifepristone, which could significantly limit access to abortion services across the United States.